Get started
Rafael Holdings, Inc.
Long

RLF *BUY*

111
Suspecting approval of Rafael’s lead AMD compound, CPI-613® (devimistat).
jfs2152
Also on:
Beyond Technical AnalysisbiotechbiotechnologyBullish PatternsTechnical IndicatorsLONGpharmaceuticalsscienceTrend Analysis

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Beyond Technical AnalysisbiotechbiotechnologyBullish PatternsTechnical IndicatorsLONGpharmaceuticalsscienceTrend Analysis
jfs2152
Also on:

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.